Infection risk in patients with small cell lung cancer receiving intensive chemotherapy and recombinant human granulocyte-macrophage colony-stimulating factor

The effect of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) was assessed in 17 patients with small cell lung cancer. GM-CSF was initially given alone by subcutaneous injection for 10 days at 50–500 μg/m 2 per day. There was a significant rise in neutrophils and eosinoph...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of cancer (1990) 1992, Vol.28 (1), p.105-112
Hauptverfasser:	Gurney, H, Anderson, H, Radford, J, Potter, M.R, Swindell, R, Steward, W, Kamthan, A, Chang, J, Weiner, J, Thatcher, N, Crowther, D
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic agents Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Biological and medical sciences Carcinoma, Small Cell - therapy Chemotaxis, Leukocyte Combined treatments (chemotherapy of immunotherapy associated with an other treatment) Female Granulocyte-Macrophage Colony-Stimulating Factor - administration & dosage Humans Infection Control Lung Neoplasms - therapy Male Medical sciences Middle Aged Neutropenia - chemically induced Neutropenia - prevention & control Phagocytosis Pharmacology. Drug treatments Recombinant Proteins - administration & dosage Risk Factors Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!